Respiratory Trials·org

Sleep medicine · Does CPAP prevent cardiovascular events?

Marin 2005 observational cohort

Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without CPAP

Marin 2005 trial design and results
Design Prospective observational cohort study
Treatment CPAP in those who accepted and tolerated it
Control Untreated apnoea, simple snorers, and healthy men
Population 1651 men: 264 healthy, 377 simple snorers, 403 untreated mild-moderate apnoea, 235 untreated severe apnoea and 372 treated with CPAP
Follow-up Mean 10.1 years
Primary endpoint Fatal and non-fatal cardiovascular events
Result Men with untreated severe disease had more fatal (1.06 per 100 person-years) and non-fatal (2.13) cardiovascular events than untreated mild-moderate disease (0.55, p=0.02; 0.89, p<0.0001), simple snorers (0.34, p=0.0006; 0.58, p<0.0001) or CPAP-treated patients.
Secondary endpoints Fatal cardiovascular events, non-fatal cardiovascular events

In men, severe obstructive sleep apnoea-hypopnoea significantly increases the risk of fatal and non-fatal cardiovascular events. CPAP treatment reduces this risk.

The trial authors, in the published abstract

How it has aged

The study that made everyone expect SAVE to be positive, and a lesson in why observational comparisons of treated and untreated patients mislead. Men who accept and tolerate CPAP differ systematically from those who do not, in ways no adjustment fully captures. When the randomised trials came, the effect did not.

Publications

Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study

Marin JM, Carrizo SJ, Vicente E, et al. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 2005 Mar 19-25;365(9464):1046-53.

  • Untreated severe sleep apnoea associated with markedly higher cardiovascular event rates
  • CPAP-treated men had event rates similar to controls
  • Observational design, with treatment self-selected rather than randomised